Industries > Pharma > Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

North America, Europe, India, Rest of the World (RoW)

PUBLISHED: 29 January 2019
PAGES: 207
PRODUCT CODE: PHA0352
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The top 10 generic drug producers have 61% share of the total revenue made by these top 50 companies. 22% of the top 50 generic drug producers are in North America. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 207-page report you will receive 74 tables and 72 figures– all unavailable elsewhere.

The 207-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017.

• Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2029 (for 18 leading companies).

• This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies – extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars – important shifts and opportunities in the industry.

• This report analyses the leading generic drug manufacturers in North America, including these companies:
• Abbott
• Akorn
• Alvogen
• Endo
• Impax
• Mallinckrodt
• Mylan
• Pfizer
• Pharmascience
• Valeant

• This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Fresenius Kabi
• Gedeon Richter
• Insud Pharma
• Krka
• Novartis (Sandoz)
• Perrigo
• Pharmstandard
• Polpharma
• Sanofi
• Stada Arzneimittel

Top Generic Drug Producers Market Forecast 2019-2029

• This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceuticals
• Aurobindo
• Lupin
• Cipla
• Dr Reddy’s
• Glenmark
• Torrent Pharma
• Cadila
• Wockhardt
• Ipca

• This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva
• EMS
• Aspen
• Sawai Pharmaceutical
• Nichi-Iko
• Abdi Ibrahim
• Towa Pharmaceutical
• Eurofarma
• Taro Pharmaceutical
• Hypermarcas

Visiongain’s study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029: North America, Europe, India, Rest of the World (RoW).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Visiongain Publishes Advanced Wound Care Market Report 2020-2030

Traditional wound care such as gauze and compression therapies are less effective than active wound care products. Active wound dressings create an environment more suitable for healing.

03 August 2020

READ

Categories

Category